| scholarly article | Q13442814 |
| P2093 | author name string | Jérôme Fayette | |
| Philippe Céruse | |||
| Julien Péron | |||
| Alpha Diallo | |||
| Marc Poupart | |||
| Eve-Marie Neidhardt | |||
| Clémentine Daveau | |||
| Antoine Ramade | |||
| Clara Fontaine-Delaruelle | |||
| Philippe Zrounba | |||
| Alexis Ambrun | |||
| P2860 | cites work | Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer | Q46932585 |
| Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. | Q30654037 | ||
| Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer | Q33377142 | ||
| Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation | Q33383864 | ||
| Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial | Q34328071 | ||
| Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer | Q34430205 | ||
| Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium | Q41260521 | ||
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients | Q43681440 | ||
| A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer | Q43821393 | ||
| Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer | Q44674194 | ||
| Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients | Q46495231 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorouracil | Q238512 |
| cisplatin | Q412415 | ||
| docetaxel | Q420436 | ||
| head and neck squamous cell carcinoma | Q18348812 | ||
| P304 | page(s) | 37297-37304 | |
| P577 | publication date | 2016-04-22 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients | |
| P478 | volume | 7 |
| Q58714240 | A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma |
| Q61814264 | Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief |
| Q50193583 | Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma |
| Q89622380 | The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality |
Search more.